Drug maker Intas Pharmaceuticals today said it has filed documents with market regulator Sebi for an initial public offer that includes sale of fresh equity worth Rs 425 crore.
"Intas Pharmaceuticals, has filed its draft red herring prospectus (DRHP) with the Securities and Exchange Board of India (Sebi) for an initial public offering," the Ahmedabad-based firm said in a statement.
The issue comprises a fresh issue equity shares aggregating up to Rs 425 crore and an offer for sale of 58.1 lakh equity shares by Mozart Ltd.
Kotak Mahindra Capital Company and Morgan Stanley India Company Pvt Ltd are the book running lead managers to the issue.
src-business-standard
Posts
No comments:
Post a Comment